Alpine Immune Sciences Depreciation & Amortization 2011-2026 | ALPN

Annual Depreciation & Amortization Alpine Immune Sciences

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
597 K	620 K	578 K	468 K	388 K	241 K	69 K	1 K	88 K	219 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
620 K	1 K	327 K

Quarterly Depreciation & Amortization Alpine Immune Sciences

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
147 K	-	-	-	140 K	-	452 K	304 K	148 K	-	482 K	327 K	165 K	-	419 K	279 K	135 K	-	344 K	229 K	305 K	-	279 K	170 K	80 K	-	165 K	101 K	46 K	-	30 K	66 K	30 K	-	47 K	31 K	16 K	-	70 K	53 K	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
482 K	16 K	181 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alector ALEC	5.72 M	$ 2.08	-14.4 %	$ 214 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
BioCardia BCDA	84 K	$ 1.36	5.04 %	$ 28.8 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
BioXcel Therapeutics BTAI	309 K	$ 1.63	-2.37 %	$ 4.13 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.65	0.97 %	$ 1.09 B	Canada
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
BeyondSpring BYSI	61 K	$ 1.36	0.37 %	$ 54.8 M	USA
Cabaletta Bio CABA	1.43 M	$ 3.36	1.05 %	$ 3.92 M	USA
Black Diamond Therapeutics BDTX	343 K	$ 2.38	-3.64 %	$ 131 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 4.83	1.68 %	$ 10.5 B	Israel
Capricor Therapeutics CAPR	1.07 M	$ 26.89	-3.72 %	$ 720 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Catalyst Biosciences CBIO	1.07 M	$ 11.55	-4.47 %	$ 760 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
C4 Therapeutics CCCC	1.96 M	$ 3.04	12.59 %	$ 252 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Codexis CDXS	4.95 M	$ 1.08	6.93 %	$ 79.3 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Cerus Corporation CERS	1.86 M	$ 2.64	2.93 %	$ 487 M	USA
Certara CERT	75.2 M	$ 7.17	1.2 %	$ 1.15 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Cullinan Management CGEM	306 K	$ 15.87	2.39 %	$ 929 M	USA
Compugen Ltd. CGEN	461 K	$ 2.24	23.76 %	$ 201 M	Israel
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Coherus BioSciences CHRS	3.2 M	$ 1.66	-0.9 %	$ 156 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 30.18	0.3 %	$ 2 B	USA